Literature DB >> 20881220

Missing data in model-based pharmacometric applications: points to consider.

Marc R Gastonguay1, Jonathan L French, Daniel F Heitjan, James A Rogers, Jae Eun Ahn, Patanjali Ravva.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20881220     DOI： 10.1177/0091270010378409

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  14 in total

1.  Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.

Authors:  François Riglet; France Mentre; Christine Veyrat-Follet; Julie Bertrand
Journal:  AAPS J       Date:  2020-02-19       Impact factor: 4.009

2.  Performance of nonlinear mixed effects models in the presence of informative dropout.

Authors:  Marcus A Björnsson; Lena E Friberg; Ulrika S H Simonsson
Journal:  AAPS J       Date:  2014-11-25       Impact factor: 4.009

3.  Modelling and simulation of the Positive and Negative Syndrome Scale (PANSS) time course and dropout hazard in placebo arms of schizophrenia clinical trials.

Authors:  Venkatesh Pilla Reddy; Magdalena Kozielska; Martin Johnson; Ahmed Abbas Suleiman; An Vermeulen; Jing Liu; Rik de Greef; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

4.  Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a β regression meta-analysis.

Authors:  James A Rogers; Daniel Polhamus; William R Gillespie; Kaori Ito; Klaus Romero; Ruolun Qiu; Diane Stephenson; Marc R Gastonguay; Brian Corrigan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-21       Impact factor: 2.745

5.  Population Pharmacokinetic Modeling in the Presence of Missing Time-Dependent Covariates: Impact of Body Weight on Pharmacokinetics of Paracetamol in Neonates.

Authors:  Wojciech Krzyzanski; Sarah F Cook; Melanie Wilbaux; Catherine M T Sherwin; Karel Allegaert; An Vermeulen; John N van den Anker
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

6.  Modeling and simulation of the exposure-response and dropout pattern of guanfacine extended-release in pediatric patients with ADHD.

Authors:  William Knebel; Jim Rogers; Dan Polhamus; James Ermer; Marc R Gastonguay
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-11-06       Impact factor: 2.745

7.  A Pharmacokinetic Analysis of Tobramycin in Patients Less than Five Years of Age with Cystic Fibrosis: Assessment of Target Attainment with Extended-Interval Dosing through Simulation.

Authors:  Kevin J Downes; Austyn Grim; Laura Shanley; Ronald C Rubenstein; Athena F Zuppa; Marc R Gastonguay
Journal:  Antimicrob Agents Chemother       Date:  2022-04-28       Impact factor: 5.191

Review 8.  Joint modeling of survival and longitudinal non-survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group.

Authors:  A Lawrence Gould; Mark Ernest Boye; Michael J Crowther; Joseph G Ibrahim; George Quartey; Sandrine Micallef; Frederic Y Bois
Journal:  Stat Med       Date:  2014-03-14       Impact factor: 2.373

9.  Comparison of methods for handling missing covariate data.

Authors:  Åsa M Johansson; Mats O Karlsson
Journal:  AAPS J       Date:  2013-10       Impact factor: 4.009

10.  Population pharmacokinetics of bevacizumab in cancer patients with external validation.

Authors:  Kelong Han; Thomas Peyret; Mathilde Marchand; Angelica Quartino; Nathalie H Gosselin; Sandhya Girish; David E Allison; Jin Jin
Journal:  Cancer Chemother Pharmacol       Date:  2016-06-21       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.